Danaher’s US$9.9b Masimo Deal Refocuses Growth On Diagnostics Valuation

robot
Abstract generation in progress

Danaher (NYSE:DHR) has agreed to acquire Masimo Corporation for $9.9 billion in a cash and stock deal, aiming to expand its presence in healthcare technology and diagnostic solutions. This acquisition positions Masimo as a standalone business within Danaher’s Diagnostics segment. The deal signifies Danaher’s strategic focus on diagnostics, coming at a time of mixed share performance for the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)